THELOGICALINDIAN - n-a
If you’re not accustomed with 23andMe, it’s a personal genome account with a mission to accommodate health, wellness, and research, while additionally allowance bodies to understand and benefit from the animal genome.
In the past, you may accept paid for a account like this and accustomed some DNA to apprentice about your own ancestry, abiogenetic makeup, and disposition for specific diseases. However, it’s now advancing to ablaze that some DNA abiogenetic testing companies accept been been benefiting from the abstracts for their own gain.
It has been appear that many bodies may accept been unaware these companies were demography their DNA abstracts and affairs it for profit. It’s been speculated that 23andMe has profited $130M affairs this abstracts – and that was afore the $300M accord with GlaxoSmithKline was announced
With the fallacies of abiogenetic testing companies acceptable added able-bodied known, there’s a growing apprehension from consumers about DNA data. That’s absolutely why TimiHealth is alive to clean assurance in the industry again.
The aggregation has launched the aboriginal tokenized analysis belvedere application blockchain to assure your bloom data, and allows you to monetize it for your OWN pocket.
How is TimiDNA Different Than Other DNA Data Companies?
On August 20th, the aggregation will launch its new “TimiDNA” belvedere and “2 Million Timicoin Giveaway” in Las Vegas at the Blockshow. At the event, the aboriginal 100,000 bodies who upload their abstracts into the belvedere will accept 20 Timicoins. That will accomplish the alignment the aboriginal to pay users for their DNA.
TimiHealth’s ambitions are to use the blockchain belvedere to accord consumers ascendancy over their bloom abstracts in one defended location, with abounding admission to their advice and the adeptness to monetize it.
What’s the Next Move For TimiHealth After the Launch?
TimiHealth is accepted to advertise new partnerships with added DNA organizations focused on agnate goals.
The Chairwoman of their Advisory Board, Joyce Lignell, explained that:
“We are additionally developing capabilities with account ally to accommodate all of the aforementioned casework as absolute genomic companies, but with the added aegis of blockchain technology and ascendancy over permission rights to allotment abstracts as you see fit. We apperceive allotment consumers is activity to be a confusing force in the genomic landscape, and we are appreciative to be the baton in this movement,”.
Healthcare Is Attracting Massive Attention
There are several added companies that could account from such an arrangement. It was appear by Crypto Briefing that Pfizer Deutschland GmbH, a German biologic giant, has been exploring blockchain technology, while IBM is widely-considered to be a beloved in developing solutions for the healthcare industry too.
In Sweden, one of the world’s best accelerating healthcare markets, CareChain intends to actualize a civic bunch that would advice adapt the absolute healthcare arrangement “owned and controlled by no-one and everyone”.
Even the acclaimed Mayo Clinic has its own exploratory affiliation with MedicalChain, a healthcare-focused aggregation in London, while it isn’t adamantine to assumption what medical startup EncrypGen does… its ticker attribute is DNA. The aggregation alike has a popup on its advanced folio that advance you leave your email address, to “find out what advisers will pay you for your genomic data”.
The columnist is not currently invested in any agenda asset.
